EMEA-000923-PIP01-10 - paediatric investigation plan

Mixture of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis (Grasses-Mix) and Secale cereale (75/25) allergen extracts
PIPHuman

Key facts

Active Substance
Mixture of Phleum pratense, Dactylis glomerata, Festuca elatior, Lolium perenne and Poa pratensis (Grasses-Mix) and Secale cereale (75/25) allergen extracts
Therapeutic area
Pneumology-allergology
Decision number
P/263/2010
PIP number
EMEA-000923-PIP01-10
Pharmaceutical form(s)
Oromucosal solution
Condition(s) / indication(s)
  • Treatment of allergic rhinitis
  • Treatment of rhino-conjuctivitis
Route(s) of administration
Sublingual use
Contact for public enquiries

LETI Pharma GmbH

paediatrics@leti.de
Germany
Phone: +49 2302202860
Fax: +49 23022028620

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date

Decision

Share this page